Topotecan-induced topoisomerase IIα expression increases the sensitivity of the CML cell line K562 to subsequent etoposide plus mitoxantrone treatment Sifeng ChenSheilachu P. GomezMark G. Mainwaring Original Article Pages: 347 - 355
Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels R. Moog A. Burger U. Massing Original Article Pages: 356 - 366
Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patients Jing LiuEric KrautKenneth K. Chan Original Article Pages: 367 - 374
The pharmacokinetics of the bispecific antibody MDX-H210 when combined with interferon gamma-1b in a multiple-dose phase I study in patients with advanced cancer Lionel D. LewisAndrew P. BeelenMarc S. Ernstoff Original Article Pages: 375 - 384
Mechanism of vinorelbine-induced radiosensitization of human small cell lung cancer cells Kazuya FukuokaHitoshi AriokaKazuto Nishio Original Article Pages: 385 - 390
Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA Zhen-Li LiuKenji OndaKitaro Oka Original Article Pages: 391 - 397
Estimation of the effect of food on the disposition of oral 5-fluorouracil in combination with eniluracil Dale R. ShepardSridhar ManiMark J. Ratain Original Article Pages: 398 - 402
Accelerated recovery from irradiation injury by angiotensin peptides Kathleen E. RodgersShiquin XiongGere S. diZerega Original Article Pages: 403 - 411
Enhanced antitumor activity of irofulven in combination with thiotepa or mitomycin C Michael J. KelnerTrevor C. McMorrisLeita Estes Original Article Pages: 412 - 418
Radiolabeled 2′-fluorodeoxyuracil-β-D-arabinofuranoside (FAU) and 2′-fluoro-5-methyldeoxyuracil-β-D-arabinofuranoside (FMAU) as tumor-imaging agents in mice Hui WangPatsy OliverDonald L. Hill Original Article Pages: 419 - 424
Phase II and pharmacokinetic study of GL331 in previously treated Chinese gastric cancer patients Jacqueline LiuLi ChenJacqueline Whang-Peng Clinical Trial Report Pages: 425 - 428